ArticleScientific reports2025
Efficacy of laparoscopic bailout surgery for moderate and severe acute cholecystitis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
"Bailout surgery" (BOS) refers to specific surgical maneuvers implemented to safely manage difficult acute cholecystitis (AC) cases and prevent complications, including massive bleeding or bile duct injury (BDI). This study validated laparoscopic BOS (lap-BOS) in moderate to severe AC cases requiring BOS. Overall, 547 patients with moderate and severe AC diagnosed per Tokyo Guideline 2018 (TG18) were retrospectively analyzed from 2020 to 2023. Of these, 129 underwent BOS, and 418 conventional laparoscopic cholecystectomy (Lap-C). Perioperative outcomes between Lap-C and BOS were compared. Patients who underwent BOS were divided into lap-BOS and conversion to open surgery (CO) groups. Patients in the BOS group were older and had higher Charlson comorbidity index scores than those in the Lap-C group. Intraoperative blood loss and operative times the rate of postoperative bile leakage were worse in the BOS group than Lap-C group. Among BOS group, the Lap-BOS group had shorter operative times, less blood loss and lower rates of complications than CO groups. BDI, postoperative bile leakage and the modified Nassar difficulty grading scales were comparable between the Lap-BOS and CO groups. Although, no differences were observed in BDI or postoperative bile leakage among Lap-C and Lap-BOS. Lap-BOS would be beneficial in avoiding common bile duct injury as for TG18 moderate and severe AC. In difficult AC cases, Lap-BOS is an alternative strategy to prevent bile duct injury of common bile duct requiring surgical intervention postoperative bile leakage and reduce intraoperative time and intraoperative bleeding rather than CO.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.